0
Systematic Review ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 1 ? Systematic review or meta-analysis. Synthesizes findings across many studies. Strongest evidence. Detection Methods Environmental Sources Gut & Microbiome Human Health Effects Marine & Wildlife Nanoplastics Policy & Risk Remediation Sign in to save

A systematic review of the potential neurotoxicity of micro-and nanoplastics: the known and unknown

Figshare 2025 Score: 58 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Vojnits, Kinga, Vojnits, Kinga, Vojnits, Kinga, Vojnits, Kinga, Vojnits, Kinga, Vojnits, Kinga, de León, Andrés, de León, Andrés, de León, Andrés, de León, Andrés, de León, Andrés, de León, Andrés, Gibon, Julien, Gibon, Julien, Gibon, Julien, Gibon, Julien, Gibon, Julien, Gibon, Julien, Barker, Philip, Barker, Philip, Barker, Philip, Barker, Philip, Barker, Philip, Barker, Philip, Mahmoudi, Morteza, Mahmoudi, Morteza, Mahmoudi, Morteza, Mahmoudi, Morteza, Mahmoudi, Morteza, Mahmoudi, Morteza, Pakpour, Sepideh Pakpour, Sepideh Pakpour, Sepideh Pakpour, Sepideh Pakpour, Sepideh Pakpour, Sepideh

Summary

This systematic review summarizes 234 research studies on how micro- and nanoplastics may harm the brain and nervous system. Evidence from animal and lab studies suggests these particles can reach the brain, potentially through the nose or by crossing the blood-brain barrier, and may cause inflammation and damage to nerve cells.

Polymers
Body Systems
Study Type Review

Abstract Background The escalating accumulation of micro- and nanoplastics (MNPs) in the environment has raised significant concerns regarding their neurotoxic potential in vertebrates. This critical review synthesizes evidence from 234 original research articles across aquatic and terrestrial models, as well as in vitro systems, to evaluate the impacts of MNPs on the brain. Main body Emerging data suggest that MNPs may reach the brain via olfactory translocation or by penetrating the blood–brain barrier, potentially facilitated by biomolecular corona formation. However, distribution kinetics, long-term retention, and true internal exposure levels remain unresolved. We highlight that neurotoxic outcomes, such as oxidative stress, cholinergic dysfunction, neurotransmitter imbalances, and neuronal apoptosis, vary widely depending on particle size, shape, polymer type, exposure concentration, and host species. Nevertheless, inconsistencies across models and experimental conditions, such as mismatches between oxidative stress markers and behavioral effects or lack of dose-response relationships, hinder mechanistic clarity and translational relevance to human health. Notably, most current studies employ spherical polystyrene particles at supraphysiological concentrations, limiting ecological and clinical extrapolation. Interactions with microbial biofilms and host microbiota are largely unexplored, despite their probable role in modulating neurotoxicity via the gut–brain axis. Moreover, most studies rely on analytical methods validated only for microplastic detection, while robust, standardized approaches for identifying nanoplastics in environmental and biological matrices remain lacking. These gaps hinder accurate exposure quantification, obscure tissue-specific accumulation patterns, and complicate human health risk estimation. Conclusion To advance the field, we recommend comprehensive physicochemical characterization of MNPs, adoption of environmentally relevant exposure scenarios, inclusion of diverse polymer types and shapes, and mechanistic integration through multi-omics and adverse outcome pathway frameworks. Addressing these challenges through harmonized methodologies and interdisciplinary collaboration is essential for developing predictive models of MNP-induced neurotoxicity and informing human health risk assessments. Graphical abstract

Sign in to start a discussion.

Share this paper